Deep Brain Stimulation for Neurological and Psychiatric Conditions

Determination of Biomarkers of the Effectiveness of Deep Brain Stimulation by Direct Electrophysiological Recordings of Brain Activity in a Cognitive Context - LFP-DBS 2024

Recruiting N/A Interventional Study
Pathology Requiring Deep Brain Stimulation Therapy
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
250 (estimated)
Sponsor
Centre Hospitalier St Anne · Other
Who this trial is looking for

This trial is looking for adults with specific neurological or psychiatric conditions who need deep brain stimulation treatment. Participants will provide information through questionnaires and undergo various tests to help understand how the treatment works.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am an adult patient
  • I have a neurological or psychiatric condition that needs treatment
  • I can understand the study procedures and complete questionnaires in French
  • I have signed the informed consent form

You may not be able to join if

  • I have contraindications to DBS, neurosurgery, or anesthesia
  • I have significant risks of bleeding or infection
  • I cannot perform neurocognitive or sensorimotor tests
  • I am not a beneficiary of a social security system

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Deep brain stimulation (DBS) is a therapeutic approach aimed at applying high-frequency, low-intensity electrical stimulation using electrodes implanted in subcortical structures and connected subcutaneously to a stimulator implanted in the abdomen. In recent years, new indications have been studied for severe and drug-resistant forms of several neurological and neuropsychiatric pathologies. Its n…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adult patient * Patient suffering from a pathology requiring treatment with deep brain stimulation: neurological disease (e.g.: Parkinson Disease, Essential Tremors, dystonia, epilepsy, etc.) or psychiatric disease (e.g.: Obsessive Compulsive Disorder, depression, eating disor…
Contacts

Philippe Domenech, Professor, MD, PhD

0033(0)149812201

philippe.domenech@ghu-paris.fr

CONTACT